BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 51680)

  • 1. Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma.
    Hollinshead AC
    Cancer; 1975 Oct; 36(4):1282-8. PubMed ID: 51680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a new oncofoetal antigen associated with several types of human carcinomas.
    Fritsché R; Mach J
    Nature; 1975 Dec; 258(5537):734-7. PubMed ID: 1207757
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed hypersensitivity skin reactions to antigens on human tumors.
    Herberman RB
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1469-73. PubMed ID: 4609389
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma.
    Giacomini P; Veglia F; Cordiali Fei P; Rehle T; Natali PG; Ferrone S
    Cancer Res; 1984 Mar; 44(3):1281-7. PubMed ID: 6692408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer skin test antigens of increased sensitivity prepared from vesicular stomatitis virus-infected tumor cells.
    Austin FC; Boone CW; Levin DL; Cavins JA; Djerassi I; Rosner D; Case R; Klein E
    Cancer; 1982 May; 49(10):2034-42. PubMed ID: 6280832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells.
    Seibert E; Sorg C; Happle R; Macher E
    Int J Cancer; 1977 Feb; 19(2):172-8. PubMed ID: 402317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A membrane antigen common to human cancer and fetal brain tissues.
    Irie RF; Irie K; Morton DL
    Cancer Res; 1976 Sep; 36(9 PT 2):3510-7. PubMed ID: 61813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines.
    Carrel S; Schreyer M; Schmidt-Kessen A; Mach JP
    Hybridoma; 1982; 1(4):387-97. PubMed ID: 6208135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and identification of soluble skin-reactive membrane antigens of malignant and normal human breast cells.
    Hollinshead AC; Jaffurs WT; Alpert LK; Harris JE; Herberman RB
    Cancer Res; 1974 Nov; 34(11):2961-8. PubMed ID: 4138143
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunofluorescent detection of antibodies to ocular melanomas.
    Wong IG; Oskvig RM
    Arch Ophthalmol; 1974 Aug; 92(2):98-102. PubMed ID: 4136249
    [No Abstract]   [Full Text] [Related]  

  • 13. Melanomas that develop within the eye inhibit lymphocyte proliferation.
    Verbik DJ; Murray TG; Tran JM; Ksander BR
    Int J Cancer; 1997 Nov; 73(4):470-8. PubMed ID: 9389558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of antibodies to MART-1 and MelanA in fine-needle aspiration samples of metastatic malignant melanoma.
    Fetsch PA; Filie AC; Steinberg SM; Abati A
    Diagn Cytopathol; 2001 Jul; 25(1):78-9. PubMed ID: 11466819
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
    McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
    J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance.
    Natali PG; Roberts JT; Difilippo F; Bigotti A; Dent PB; Ferrone S; Liao SK
    Cancer; 1987 Jan; 59(1):55-63. PubMed ID: 3539308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular immunity in patients with melanoma].
    Gorodinova VV; Kholenshed A; Babakova SV
    Vopr Onkol; 1976; 22(12):3-5. PubMed ID: 1020253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of soluble human melanoma-associated antigens.
    Roth JA; Slocum HK; Pellegrino MA; Holmes EC; Reisfeld RA
    Cancer Res; 1976 Jul; 36(7 PT 1):2360-4. PubMed ID: 776393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in cell binding patterns of two monoclonal antibodies recognizing distinct epitopes on a human melanoma-associated oncofetal antigen.
    Liao SK; Khosravi MJ; Brown JP; Kwong PC
    Mol Immunol; 1987 Jan; 24(1):1-9. PubMed ID: 2441244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma membrane-associated antigens on tumor cells derived from transitional-cell carcinoma of the human urinary bladder. II. Identification at the molecular level of plasma membrane-associated antigens.
    Schneider MU; Paulie S; Troye M; Perlmann P
    Int J Cancer; 1980 Aug; 26(2):193-202. PubMed ID: 7203713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.